Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heartburn drug aims to outperform standard treatment in major trial

NCT ID NCT07313774

Summary

This study is testing whether a new medication called linaprazan glurate works better than the commonly used drug lansoprazole at keeping the esophagus healed in people with acid reflux disease (GERD). About 1050 adults who have already had their esophagus damage healed in a previous study will take one of the treatments daily for up to a year. Doctors will use camera scopes to check if the healing is maintained and monitor for side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.